Psychedelic substances: Can they help with mental disorders?
Published
Researchers around the world are investigating whether psychedelic substances can be used in the treatment of mental disorders. The topic is receiving increasing attention, also in Norway. Many patients do not get sufficiently good help today, and therefore researchers are looking for new ways to treat illnesses such as depression and anxiety.
Psychedelic substances are substances that affect the brain and how we perceive thoughts, feelings and surroundings. Among the best known are psilocybin, which is found in certain mushrooms, and LSD. In Norway, these substances are currently regulated as narcotics. They may only be used in research or in special medical situations.
Some studies suggest that the substances can bring improvement for people with depression, anxiety and post-traumatic stress disorder. The treatment usually takes place under controlled conditions, and it is often combined with talk therapy. Many of the studies are nevertheless small, and researchers emphasise that more knowledge is needed about both long-term effects and possible risks.
So far, psychedelic treatment is not common in the Norwegian health care system. Researchers and health authorities are concerned with being cautious and building on solid results. Developments in this field should therefore be followed closely in the coming years.
Sources: NHI.no
More Norway news
- Cybersecurity has become a leadership responsibility
- Former soldier has built challenger to OBOS
- More Customers Don't Necessarily Mean Better Profitability
- New Norway chief at Advania
- Professor Moumita Sen researches religion, politics and power
- Conference in Oslo to examine how Norwegian life sciences can reach their potential
- From Emissions to Resource: Can CO₂ Be Used in New Industry?
- Norway heard in the EU's new Arctic strategy